Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Amino Acids share these classifications
NEWS AND VIEWS A two-in-one drug that modulates neural pathways involved in appetite and reward might prove to be more effective and longer lasting than current weight-loss drugs on the market
Inno Shred GLP-1 SUPPORT HEALTHY GLP1 LEVELS TO MANAGE APPETITE AND SUPPORT YOUR BODY COMPOSITION GOALS * SUPPORT HEALTHY GLP1 LEVELS TO MANAGE APPETITE AND SUPPORT YOUR BODY COMPOSITION GOALS * Taking Inno Shred GLP1 supports: * GLP-1 Related Processes to Help Manage Appetite* Your Bodys Natural Fat-Burning Power, Even While Resting* Clean, Sustained Energy to Power Through Your Day and Workouts* Support Enhanced Alertness and Optimal Performance* Improved Fat-Burning Efficiency to Turn Stored Fat into Fuel* HOW INNO SHRED GLP1 SUPPORTS HEALTHY GLP1 LEVELS WHILE OPTIMIZING FAT METABOLISM * SUPPORT GLP-1 RELATED PROCESSES* Powered by Berberine Hydrochloride and Sukre, it helps support your bodys natural GLP-1 processes to help tame unwanted food urges.* FEND OFF CRAVINGS FOR SUGARY, CARB-HEAVY FOODS* Chromium Picolinate supports balanced energy levels and helps resist carb-loaded temptations.* SUPPORT FAT METABOLISM* The combination of Paradoxine and Rauwolscine supports the conversion of white fat into energy-utilizing brown fat and helps increase thermogenesis.* SUPPORT METABOLIC ACTIVITY* Chromium Picolinate helps your body utilize carbs for energy, supporting healthy fat storage.* UNLEASH CLEAN, ALLDAY ENERGY* Theobromine and Green Coffee Bean Extract support sustained energy, focus, and motivation.* SUPPORT FAT METABOLISM* The combination of Paradoxine and Rauwolscine supports the conversion of white fat into energy-utilizing brown fat and helps increase thermogenesis.* EXPERIENCE THE SYNERGY OF OUR GLP-1 SUPPORTING + FAT-BURNING FORMULA* HELP MANAGE APPETITE, SUPPORT FAT METABOLISM, AND PROMOTE METABOLIC ACTIVITY TO ASSIST HEALTHY WEIGHT MANAGEMENT
doi:10.1007/s11739-023-03281-0 89
10.1001/jama.288.23.2981 250 OmboniS.MalaccoE.ParatiG
W.van RamshorstB.et al (2016)
